(Q34736052)

4 August 2017

title

Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality (English)

1 reference

4 August 2017

Oguzhan Alagoz

6

0 references

Elizabeth S Burnside

object named as

Elizabeth S Burnside

8

0 references

Sylvia Plevritis

19

object named as

Sylvia K Plevritis

1 reference

4 August 2017

18

Jeanne S Mandelblatt

1 reference

4 August 2017

Diego Munoz

1

1 reference

4 August 2017

Aimee M Near

2

1 reference

4 August 2017

Nicolien T van Ravesteyn

3

1 reference

4 August 2017

Sandra J Lee

4

1 reference

4 August 2017

Clyde B Schechter

5

1 reference

4 August 2017

Donald A Berry

7

1 reference

4 August 2017

Yaojen Chang

9

1 reference

4 August 2017

Gary Chisholm

10

1 reference

4 August 2017

Harry J de Koning

11

1 reference

4 August 2017

Mehmet Ali Ergun

12

1 reference

4 August 2017

Eveline A M Heijnsdijk

13

1 reference

4 August 2017

Hui Huang

14

1 reference

4 August 2017

Natasha K Stout

15

1 reference

4 August 2017

Brian L Sprague

16

1 reference

4 August 2017

Amy Trentham-Dietz

17

1 reference

4 August 2017

language of work or name

English

0 references

publication date

24 September 2014

1 reference

Journal of the National Cancer Institute

4 August 2017

published in

1 reference

4 August 2017

volume

106

1 reference

4 August 2017

issue

11

1 reference

Sex hormone levels and risk of breast cancer with estrogen plus progestin

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

7 July 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Effect of three decades of screening mammography on breast-cancer incidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Online tool to guide decisions for BRCA1/2 mutation carriers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Adjuvant trastuzumab in HER2-positive breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Breast cancer adjuvant therapy: time to consider its time-dependent effects.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Rethinking screening for breast cancer and prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

7 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Gene-expression signatures in breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Effect of screening and adjuvant therapy on mortality from breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Biomarkers in cancer staging, prognosis and treatment selection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Quality of Cochrane reviews: assessment of sample from 1998

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271026

Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU289

The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU289

Modeling the dissemination of mammography in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU289

Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU289

Quality of life valuations of mammography screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU289

Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU289

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU289

The influence of young age on outcome in early stage breast cancer

21 January 2018

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Is age at diagnosis an independent prognostic factor for survival following breast cancer?

1 reference

12 December 2020

Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999

1 reference

12 December 2020

Changing patterns in breast cancer incidence trends

1 reference

12 December 2020

The Wisconsin Breast Cancer Epidemiology Simulation Model

1 reference

12 December 2020

Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer

1 reference

12 December 2020

A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015

1 reference

12 December 2020

The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU289

1 reference

4 August 2017

1 reference

4 August 2017

1 reference